Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 108051-108100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT03584022
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
NAActive, not recruiting
20 participants
Started: Nov 9, 2018 · Completed: Mar 31, 2027
6 conditions1 sponsor1 location
NCT03698149
ECoG BMI for Motor and Speech Control
NARecruiting
3 participants
Started: Nov 9, 2018 · Completed: Aug 15, 2030
5 conditions2 sponsors1 location
NCT04239144
Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease
NARecruiting
45 participants
Started: Nov 9, 2018 · Completed: Mar 9, 2026
2 conditions2 sponsors1 location
NCT03593018
Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients with Relapsed or Refractory AITL
PHASE3Active, not recruiting
86 participants
Started: Nov 9, 2018 · Completed: Dec 31, 2025
2 conditions2 sponsors27 locations
NCT03704480
Durvalumab + Tremelimumab ± Paclitaxel in Advanced BTC After Platinum Chemotherapy.
PHASE2Active, not recruiting
106 participants
Started: Nov 9, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors28 locations
NCT03802799
Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
PHASE2/PHASE3Enrolling by invitation
550 participants
Started: Nov 9, 2018 · Completed: Aug 31, 2027
1 condition1 sponsor26 locations
NCT03728972
Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal Type
PHASE2Active, not recruiting
19 participants
Started: Nov 9, 2018 · Completed: Nov 30, 2026
2 conditions1 sponsor10 locations
NCT03683355
Characterization of RadiOlabeled Tracer Uptake Pattern in Noninfected Transcatheter Aortic Valves.
N/AActive, not recruiting
30 participants
Started: Nov 9, 2018 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT04160429
Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations
N/ARecruiting
100 participants
Started: Nov 9, 2018 · Completed: Jul 30, 2029
2 conditions2 sponsors1 location
NCT04947098
Prevent Cancer- Greenville
N/ARecruiting
1,000 participants
Started: Nov 8, 2018 · Completed: Nov 8, 2029
2 conditions1 sponsor1 location
NCT03881605
MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients with Triple Negative or HER2+ MBC
NAActive, not recruiting
50 participants
Started: Nov 8, 2018 · Completed: Dec 31, 2025
4 conditions2 sponsors1 location
NCT04048278
Lidocaine Infusion in Pancreatic Cancer
EARLY_PHASE1Recruiting
46 participants
Started: Nov 8, 2018 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04002440
Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight
NAActive, not recruiting
28 participants
Started: Nov 8, 2018 · Completed: Apr 30, 2022
2 conditions4 sponsors2 locations
NCT03687814
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NARecruiting
78 participants
Started: Nov 8, 2018 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT03394417
StrataXRT vs Standard Clinical Practice for the Prevention of Acute Dermatitis in Head and Neck Cancers Patients
NARecruiting
100 participants
Started: Nov 8, 2018 · Completed: Jun 30, 2027
2 conditions1 sponsor1 location
NCT03434314
Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging
NAActive, not recruiting
500 participants
Started: Nov 8, 2018 · Completed: Jun 30, 2025
1 condition10 sponsors29 locations
NCT03741673
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
PHASE3Recruiting
180 participants
Started: Nov 8, 2018 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT04086875
A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer
NAActive, not recruiting
332 participants
Started: Nov 7, 2018 · Completed: Sep 24, 2024
21 conditions2 sponsors7 locations
NCT03736590
Clinic-Based Financial Coaching and Family Health and Development
NAActive, not recruiting
400 participants
Started: Nov 7, 2018 · Completed: Jul 31, 2030
3 conditions1 sponsor1 location
NCT03588299
"Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a Shuttle"
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Nov 7, 2018 · Completed: Nov 3, 2026
1 condition2 sponsors13 locations
NCT03795311
Evaluation of the Efficacy and the Safety of FOLFIRINOX3 Bevacizumab Treatment in Patients With Colorectal Cancer (FOLFIRINOX 3)
PHASE1/PHASE2Active, not recruiting
32 participants
Started: Nov 7, 2018 · Completed: Jul 16, 2025
1 condition1 sponsor1 location
NCT03541096
Winter-Swimming and Brown Adipose Tissue Activity in Middel-aged Obese Subjects (WinterBAT).
NAActive, not recruiting
30 participants
Started: Nov 7, 2018 · Completed: Dec 31, 2025
7 conditions1 sponsor1 location
NCT03620942
Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System
NAActive, not recruiting
173 participants
Started: Nov 7, 2018 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT03672539
Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome
PHASE2Active, not recruiting
50 participants
Started: Nov 7, 2018 · Completed: Nov 30, 2025
6 conditions2 sponsors1 location
NCT04004312
Single Fractions SBRT for Prostate Cancer
NARecruiting
12 participants
Started: Nov 7, 2018 · Completed: Dec 20, 2027
1 condition2 sponsors1 location
NCT04242602
Multimodal Monitoring of Cerebral Autoregulation After Pediatric Brain Injury
NARecruiting
30 participants
Started: Nov 6, 2018 · Completed: Jan 31, 2030
3 conditions3 sponsors1 location
NCT03667404
Resistant Maltodextrin for Gut Microbiome in Parkinson's Disease: Safety and Tolerability Study
PHASE2Active, not recruiting
30 participants
Started: Nov 6, 2018 · Completed: Mar 31, 2026
3 conditions2 sponsors1 location
NCT03712566
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
N/AActive, not recruiting
39 participants
Started: Nov 6, 2018 · Completed: Jul 31, 2026
5 conditions1 sponsor1 location
NCT03769415
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
NARecruiting
500 participants
Started: Nov 6, 2018 · Completed: Dec 15, 2030
1 condition3 sponsors2 locations
NCT03703375
Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma
PHASE3Active, not recruiting
93 participants
Started: Nov 6, 2018 · Completed: Mar 31, 2026
1 condition1 sponsor12 locations
NCT03734107
Improving Health Communication During the Transition From Pediatric to Adult Diabetes Care
NAActive, not recruiting
52 participants
Started: Nov 6, 2018 · Completed: Dec 15, 2024
1 condition2 sponsors1 location
NCT03581292
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations
PHASE2Active, not recruiting
38 participants
Started: Nov 6, 2018 · Completed: Oct 16, 2025
3 conditions1 sponsor163 locations
NCT03740282
Early Weight-Bearing After the Lapiplasty Procedure
NAActive, not recruiting
183 participants
Started: Nov 6, 2018 · Completed: May 31, 2026
2 conditions1 sponsor7 locations
NCT03563417
ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO
NARecruiting
1,560 participants
Started: Nov 6, 2018 · Completed: Nov 1, 2032
2 conditions1 sponsor27 locations
NCT03825250
The Val-CARD Trial
PHASE1/PHASE2Recruiting
122 participants
Started: Nov 6, 2018 · Completed: Oct 7, 2024
3 conditions1 sponsor1 location
NCT04045587
International Severe Asthma Registry: Canadian Cohort
N/ARecruiting
714 participants
Started: Nov 6, 2018 · Completed: Dec 31, 2028
1 condition10 sponsors12 locations
NCT03661320
A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer
PHASE3Active, not recruiting
855 participants
Started: Nov 6, 2018 · Completed: Dec 30, 2027
2 conditions2 sponsors172 locations
NCT03729739
Functional Assessment by Virtual Online Reconstruction. The FAVOR III Europe Trial
NAActive, not recruiting
2,001 participants
Started: Nov 6, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors35 locations
NCT03686007
Multimedia Self-Management Intervention for Lung Cancer Surgery Family Caregivers and Patients
NAActive, not recruiting
380 participants
Started: Nov 6, 2018 · Completed: Jan 13, 2026
10 conditions2 sponsors1 location
NCT03652064
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
PHASE3Active, not recruiting
395 participants
Started: Nov 6, 2018 · Completed: Jan 9, 2026
1 condition1 sponsor114 locations
NCT03818334
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
PHASE2/PHASE3Recruiting
50 participants
Started: Nov 6, 2018 · Completed: Nov 1, 2026
5 conditions1 sponsor1 location
NCT03734237
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
PHASE4Active, not recruiting
15,449 participants
Started: Nov 6, 2018 · Completed: May 31, 2024
3 conditions8 sponsors9 locations
NCT04599621
Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome
N/ARecruiting
3 participants
Started: Nov 5, 2018 · Completed: Dec 28, 2027
1 condition1 sponsor1 location
NCT03716180
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
PHASE1Active, not recruiting
100 participants
Started: Nov 5, 2018 · Completed: Sep 1, 2030
1 condition4 sponsors5 locations
NCT03649048
Low-Dose Weekly vs High-Dose Cisplatin
NARecruiting
100 participants
Started: Nov 5, 2018 · Completed: Sep 30, 2028
1 condition1 sponsor3 locations
NCT03415763
Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy
PHASE3Recruiting
764 participants
Started: Nov 5, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05268783
Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk
NARecruiting
1,000 participants
Started: Nov 5, 2018 · Completed: Dec 31, 2029
1 condition1 sponsor7 locations
NCT03570931
A Study to Assess Efficacy and Safety of RT001 in Subjects With Infantile Neuroaxonal Dystrophy
PHASE2/PHASE3Active, not recruiting
19 participants
Started: Nov 5, 2018 · Completed: Jun 30, 2022
1 condition1 sponsor2 locations
NCT03608579
Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OA
PHASE1Active, not recruiting
24 participants
Started: Nov 5, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03705585
CVD 38000: Study of Responses to Vaccination With Typhoid and/or Cholera
PHASE4Recruiting
240 participants
Started: Nov 5, 2018 · Completed: May 31, 2029
1 condition1 sponsor1 location